Ahmed Shata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Shata has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Sameh Saber
Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt
13 shared publications - Elsayed A. Elmorsy
Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah 52571, Saudi Arabia; Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
6 shared publications - Nesreen Elsayed Morsy
Pulmonary Medicine Department, Faculty of Medicine, Mansoura University Sleep Center, Mansoura University, Mansoura 35516, Egypt
6 shared publications - Rabab Salem Hamad
Biological Sciences Department, College of Science, King Faisal University, Al Ahsa, 31982, Saudi Arabia
6 shared publications Ahmed Abdel-Monem Elmetwally
Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
5 shared publicationsHanan Eissa
Department of Pharmacology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
5 shared publications
Latest Publications
- 16 July 2026
- Published by Elsevier in Tissue and Cell
- Vol. 104 (Pt 1) , 103797
BD1-biased BET inhibition attenuates TXNIP-associated inflammation in diabetic MASH
- 16 July 2026
- Published by Elsevier in Tissue and Cell
- Vol. 104 (Pt 1) , 103797
BD1-biased BET inhibition attenuates TXNIP-associated inflammation in diabetic MASH
- 24 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103733
Interrupting a mitochondrial DNA–driven innate immune circuit attenuates hepatic tissue remodeling and fibrotic architecture in experimental steatohepatitis
- 24 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103733
Interrupting a mitochondrial DNA–driven innate immune circuit attenuates hepatic tissue remodeling and fibrotic architecture in experimental steatohepatitis
- 10 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103692
VPS13C-mediated endoplasmic reticulum-lysosome tethering in neuronal stress responses
- 10 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103692
VPS13C-mediated endoplasmic reticulum-lysosome tethering in neuronal stress responses
- 3 March 2026
- Published by Elsevier in Tissue and Cell
- Vol. 101, 103431
The nano–biointerface as a structural regulator of cell behavior: Interactions of extracellular vesicles, synthetic nanocarriers, and nanofibers with cells
- 3 March 2026
- Published by Elsevier in Tissue and Cell
- Vol. 101, 103431
The nano–biointerface as a structural regulator of cell behavior: Interactions of extracellular vesicles, synthetic nanocarriers, and nanofibers with cells
- 1 September 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 165, 115452
MDL-800 protects against inflammatory and metabolic dysfunction: role of SIRT6 in the cross-regulation of NFκB, AMPK, and PPAR signaling in rats
- 1 September 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 165, 115452
MDL-800 protects against inflammatory and metabolic dysfunction: role of SIRT6 in the cross-regulation of NFκB, AMPK, and PPAR signaling in rats
- Open Access
- 17 March 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 161, 114553
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
- 17 March 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 161, 114553
Open AccessMirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
- RetractedOpen Access
- 2 January 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 158, 114196
RETRACTED: Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
- 2 January 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 158, 114196
RetractedOpen AccessRETRACTED: Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
- RetractedOpen Access
- 5 September 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 154, 113651
Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis
- 5 September 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 154, 113651
RetractedOpen AccessDiacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis
- Open Access
- 30 July 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 153, 113487
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis
- 30 July 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 153, 113487
Open AccessPimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis